Understanding diabetic teratogenesis: where are we now and where are we going?
about
Maternal diet modulates placenta growth and gene expression in a mouse model of diabetic pregnancyDiabetic complications in pregnancy: is resveratrol a solution?Genetic, epigenetic, and environmental contributions to neural tube closureModeling anterior development in mice: diet as modulator of risk for neural tube defectsProgenitor cell dysfunctions underlie some diabetic complicationsResveratrol prevents impairment in activation of retinoic acid receptors and MAP kinases in the embryos of a rodent model of diabetic embryopathy.Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomesHyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis.Increased DNA methyltransferase 3b (Dnmt3b)-mediated CpG island methylation stimulated by oxidative stress inhibits expression of a gene required for neural tube and neural crest development in diabetic pregnancy.Use of a murine embryonic stem cell line that is sensitive to high glucose environment to model neural tube development in diabetic pregnancyThe effect of maternal diabetes on the Wnt-PCP pathway during embryogenesis as reflected in the developing mouse eye.Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in miceEven a Chronic Mild Hyperglycemia Affects Membrane Fluidity and Lipoperoxidation in Placental Mitochondria in Wistar RatsVasoactive exposures during pregnancy and risk of microtia.AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathy.Hyperglycemia impairs left-right axis formation and thereby disturbs heart morphogenesis in mouse embryos.Diabetic embryopathy: a developmental perspective from fertilization to adulthood.N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes.Analysis of maternal risk factors associated with congenital vertebral malformations.Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks.Genetic basis of susceptibility to teratogen induced birth defects.Maternal diabetes mellitus and the origin of non-communicable diseases in offspring: the role of epigenetics.Mitochondrial one-carbon metabolism and neural tube defects.Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals.Genetic Advances in the Understanding of Microtia.Delay in rat lung alveolarization after the combined exposure of maternal hyperglycemia and postnatal hyperoxia.The CTIS Womb to Classroom Screening Program for the detection of agents with adverse effects on neuropsychological development.Microtia: epidemiology and genetics.Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study.Spectrum of congenital anomalies in pregnancies with pregestational diabetesRisk of birth defects associated with maternal pregestational diabetesA comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats
P2860
Q21560980-1D885CEE-7E5A-49B1-9BCB-FE65D1122CB8Q27012844-7EFC9A64-2AB3-44DD-8B09-921C9DC97DA0Q27015138-B67DA378-8527-4A88-95C1-95026A2F3964Q27028231-2C99AF2F-61E8-4333-AEA2-CB5ECFC4B739Q28086990-3ACF500B-1CE2-484A-B147-4B19C81F9C53Q33714227-F46E4246-D0C1-4864-8EAB-624C389BCA73Q33757724-079C2632-C6D7-4ADF-B77A-8357B2AE7326Q33796342-2B6C3672-2C34-4A33-A7DC-23643B1C4561Q34227874-3C59F88A-D57D-4DFA-99CD-D88D4698C551Q34452969-5705D3C2-2C45-4D16-8A5A-FD074F0C0197Q35041358-D595C129-2C5C-463D-B54E-827351FC98CCQ35565619-D2E6C923-3A0F-4BA7-8185-5781392C9363Q35858920-4AA5B77D-948C-4E15-B761-9CB1DBADFFD5Q35906721-B77FEECC-4258-4764-95D7-1F2360C6DF72Q35927533-07F4410F-7F0E-4AAD-8621-492A6C0E4003Q36103084-B8F837A5-8143-4CB2-9149-2BBDA24E413BQ36802351-F70978CC-4B87-4AD6-95D4-832CA07A87CEQ37616698-3583572F-97F0-44A3-B202-D4004707E001Q37648260-81B5F658-324E-4550-9714-4EDDFFAA0D54Q37695522-B9BF948C-4D59-40C8-B72C-43D0DD85575EQ37902133-9F4AFD1E-1313-494F-9600-5AE8F199904FQ38211819-89878D47-1099-42C9-9DE9-0A49F9D8A183Q38225378-E08B196A-1C68-4B88-B97E-EC2BD9E21DD8Q38792368-7409FDD8-A0D1-412E-9C27-65EB2EF7245EQ39023014-C6C60E35-C9FC-4667-B25F-2C19626AF5B0Q44488466-61E4A710-0AFB-41A8-B781-0034233F6A29Q46020317-6998FE6A-F16B-42EC-A2C1-C8155933F805Q52618600-562F5150-8FD8-4049-A8D7-F514D41B8EADQ53696151-DD31126F-6469-4488-B384-80F4D7D2A077Q57077336-9711825C-4575-4D1C-A502-8D664ADC6EBFQ58327950-1EE89B40-897A-40DE-BAC1-FA9F31382094Q58792938-7B3A51B9-56B3-4034-B11C-21D6CC6CFAB2
P2860
Understanding diabetic teratogenesis: where are we now and where are we going?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding diabetic teratogenesis: where are we now and where are we going?
@en
Understanding diabetic teratogenesis: where are we now and where are we going?
@nl
type
label
Understanding diabetic teratogenesis: where are we now and where are we going?
@en
Understanding diabetic teratogenesis: where are we now and where are we going?
@nl
prefLabel
Understanding diabetic teratogenesis: where are we now and where are we going?
@en
Understanding diabetic teratogenesis: where are we now and where are we going?
@nl
P2860
P356
P1476
Understanding diabetic teratogenesis: where are we now and where are we going?
@en
P2093
Sheller Zabihi
P2860
P304
P356
10.1002/BDRA.20704
P577
2010-10-01T00:00:00Z